These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2847515)

  • 1. [Studies on the interaction of interferon with anti-herpetic agents].
    Naito T
    Nippon Ganka Gakkai Zasshi; 1988 Jul; 92(7):1177-84. PubMed ID: 2847515
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
    Naito T; Shiota H; Nitta K; Mimura Y
    Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the cytotoxicity of a new anti-herpetic agent, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, on the rabbit cornea].
    Naito T; Shiota H; Kanematsu S; Mimura Y; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1988 Apr; 92(4):573-7. PubMed ID: 2841833
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
    Eppstein DA; Marsh YV
    Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
    Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
    Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to antiviral drugs at last.
    N Z Med J; 1989 Sep; 102(875):487. PubMed ID: 2550860
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay.
    Moran DM; Kern ER; Overall JC
    J Infect Dis; 1985 Jun; 151(6):1116-22. PubMed ID: 2987369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis].
    Mori Y; Inoue Y; Shimomura Y; Manabe R
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):484-7. PubMed ID: 2171305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid antiviral drug test by enzyme-linked immunoassay.
    Landini MP; Baldassarri B
    Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
    Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
    Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virus.
    Chun YS; Park NH
    Antimicrob Agents Chemother; 1987 Feb; 31(2):349-51. PubMed ID: 3032100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons.
    Rasmussen L; Chen PT; Mullenax JG; Merigan TC
    Antimicrob Agents Chemother; 1984 Oct; 26(4):441-5. PubMed ID: 6097163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
    Lerner AM; Bailey EJ
    J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
    [No Abstract]   [Full Text] [Related]  

  • 16. [The course for a successor for acyclovir].
    Ramos JM; Belinchón I
    Rev Clin Esp; 1996 Nov; 196(11):761-5. PubMed ID: 9132841
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined effects of flavonoids and acyclovir against herpesviruses in cell cultures.
    Mucsi I; Gyulai Z; Béládi I
    Acta Microbiol Hung; 1992; 39(2):137-47. PubMed ID: 1339152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
    Russler SK; Tapper MA; Carrigan DR
    Lancet; 1989 Aug; 2(8659):382. PubMed ID: 2569565
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of resistance to antiviral drugs.
    Renis HE; Buthala DA
    Ann N Y Acad Sci; 1965 Jul; 130(1):343-54. PubMed ID: 4285582
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses.
    Bowden RA; Digel J; Reed EC; Meyers JD
    J Infect Dis; 1987 Dec; 156(6):899-903. PubMed ID: 2824624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.